Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Prevention02:59

Cancer Prevention

8.7K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
8.7K
Cancer Prevention02:59

Cancer Prevention

3.0K
3.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.7K
1.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

5.1K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.8K
1.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bacterial Nanocellulose Hydrogels as a Next-Generation Biomaterial for Cardiac and Vascular Tissue Engineering: Structural, Biological, and Translational Perspectives.

Gels (Basel, Switzerland)·2026
Same author

From Toxin to Therapy: Biomedical Applications of Bee Venom in Cancer, Diabetes, and Neurodegenerative Disorders.

International journal of molecular sciences·2026
Same author

Physical Exercise Counteracts Impaired Cognition by Improving Mitochondrial Function.

International journal of molecular sciences·2026
Same author

Extracellular vesicles in stem cell-based gonadal regeneration: mechanisms, therapeutic potential, and translational challenges.

Frontiers in veterinary science·2026
Same author

Bovine Spongiform Encephalopathy: An Integrated Review of Prion Mechanisms, Neuroanatomy, and Control.

Veterinary sciences·2026
Same author

The 3D Collagen Network as a Determinant of Tumor Progression and Drug Delivery Efficiency in Breast Cancer.

Pharmaceutics·2026

Related Experiment Video

Updated: Mar 29, 2026

Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts
09:20

Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts

Published on: June 26, 2018

8.9K

Imperatorin: A Furanocoumarin with Potential in Combating Cancer Development and Progression-A Comprehensive Review.

Victória Dogani Rodrigues1, Cláudia Rucco Penteado Detregiachi2, Manuela Dos Santos Bueno2

  • 1Department of Biochemistry and Pharmacology, School of Medicine, Faculdade de Medicina de Marília (FAMEMA), Marília 17519-030, SP, Brazil.

Pharmaceuticals (Basel, Switzerland)
|March 28, 2026
PubMed
Summary

Imperatorin, a natural compound, shows significant anticancer potential by targeting multiple pathways and influencing the tumor microenvironment. Further research is needed to overcome its pharmacokinetic limitations for clinical application.

Keywords:
anticancer activityapoptosiscell cycle arrestchemopreventioncoumarinsimperatorinmetastasis inhibitionphytochemicals

More Related Videos

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells
13:38

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Published on: January 18, 2017

12.8K
Author Spotlight: Liujunzi Decoction as a Traditional Chinese Treatment for Coloproctitis Cancer
06:24

Author Spotlight: Liujunzi Decoction as a Traditional Chinese Treatment for Coloproctitis Cancer

Published on: October 13, 2023

1.8K

Related Experiment Videos

Last Updated: Mar 29, 2026

Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts
09:20

Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts

Published on: June 26, 2018

8.9K
Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells
13:38

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Published on: January 18, 2017

12.8K
Author Spotlight: Liujunzi Decoction as a Traditional Chinese Treatment for Coloproctitis Cancer
06:24

Author Spotlight: Liujunzi Decoction as a Traditional Chinese Treatment for Coloproctitis Cancer

Published on: October 13, 2023

1.8K

Area of Science:

  • Pharmacology
  • Oncology
  • Natural Products Chemistry

Background:

  • Imperatorin, a furanocoumarin from medicinal plants, exhibits diverse pharmacological activities.
  • Growing interest in imperatorin's anticancer potential necessitates a comprehensive review of preclinical evidence.

Purpose of the Study:

  • To synthesize current preclinical and pharmacological data on imperatorin in cancer.
  • To consolidate mechanistic pathways, identify therapeutic opportunities, and outline future research directions for imperatorin as an anticancer agent.

Main Methods:

  • Literature review of in vitro and in vivo studies on imperatorin's anticancer effects.
  • Analysis of molecular mechanisms, pharmacokinetic properties, and safety data.
  • Exploration of recent advances in imperatorin genetics and biosynthesis.

Main Results:

  • Imperatorin demonstrates multi-targeted antitumor effects, including apoptosis induction, proliferation inhibition, and angiogenesis suppression.
  • It modulates the tumor microenvironment by reducing inflammation and enhancing immune-cell cytotoxicity.
  • Pharmacokinetic limitations (low bioavailability, protein binding) and safety concerns hinder clinical translation.

Conclusions:

  • Imperatorin is a promising anticancer candidate with broad-spectrum activity.
  • Addressing pharmacokinetic and safety challenges through improved delivery systems and further research is crucial.
  • Investigating additional regulatory pathways and biosynthetic processes will enhance its therapeutic potential.